Semen News and Research

RSS

Semen is an organic fluid, also known as seminal fluid, that usually contains spermatozoa. It is secreted by the gonads (sexual glands) and other sexual organs of male or hermaphroditic animals and can fertilize female ova. The process of discharge is called ejaculation.

FDA approves Abbott's new Chagas in vitro diagnostic test

Abbott received approval from the U.S. Food and Drug Administration (FDA) for a new Chagas in vitro diagnostic test.

21 Nov 2011

Swissmedic approves REVLIMID for treatment of myelodysplastic syndromes

Celgene International Sàrl, a subsidiary of Celgene Corporation, today announced that REVLIMID (lenalidomide) has been granted approval by the Swiss agency for Therapeutic Products (Swissmedic) for use in patients with transfusion-dependent anemia due to low-or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenic abnormality with or without additional cytogenic abnormalities.

21 Nov 2011

Anti-HIV vaginal gel could also reduce genital herpes by half: Study

The study appears this week in the journal Cell Host & Microbe that tested the gel on women in South Africa (where the risk of HIV and herpes is great) found that the anti-HIV/AIDS drug tenofovir reduced herpes infections by 51% and HIV infections by 39%.

24 Oct 2011

A Daddy’s heart is healthier: Study

A new study shows that fathers are less likely to die of heart disease than men who’ve never had kids. This raises questions about a possible biological link between male infertility and overall health. Other recent studies have found a connection between testicular and prostate cancer and infertility.

27 Sep 2011

Synthetic lectins inhibit HIV from entering cells

University of Utah researchers have discovered a new class of compounds that stick to the sugary coating of the AIDS virus and inhibit it from infecting cells - an early step toward a new treatment to prevent sexual transmission of the virus.

23 Sep 2011

E.U. CHMP issues positive opinion for use of Celgene's REVLIMID/dexamethasone MM drug

Celgene International Sàrl was notified today that the E.U. Committee for Medicinal Products for Human Use (CHMP), on behalf of the European Medicines Agency (EMA) has concluded an Article 20 review of REVLIMID and issued a positive opinion for the use of REVLIMID in combination with dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.

23 Sep 2011

New microbicide may block AIDS virus from infecting cells

23 Sep 2011

Sperm bank spurns potential redhead donors

Cryos International, one of the world's largest sperm banks is refusing potential donors who have red hair. The bank's director told the Danish newspaper Ekstrabladet that there simply wasn't much demand for sperm from red-headed men.

20 Sep 2011

UCLA develops dual-mode microscope that uses holograms instead of lenses

To serve remote areas of the world, doctors, nurses and field workers need equipment that is portable, versatile, and relatively inexpensive. Now researchers at the University of California at Los Angeles (UCLA) have built a compact, light-weight, dual-mode microscope that uses holograms instead of lenses.

31 Aug 2011

Antioxidants may help treat infertility problems in both women and men

A growing body of evidence suggests that antioxidants may have significant value in addressing infertility issues in both women and men, including erectile dysfunction, and researchers say that large, specific clinical studies are merited to determine how much they could help.

29 Jul 2011

Fiscal problems could be mitigated by ART conceived children

In 2009, 1,547 ART children were born in public clinics in Denmark, projecting a net tax revenue of -224 million and -247 million in 25 and 50 years respectively. The authors of the study calculated that reductions of 30-50% in ART cycles following the new policy would lead to cost savings of -67 - -111 million for the Danish government in 2034.

6 Jul 2011

Research offers avenue for creating Alzheimer's and HIV therapeutics

A new advance by UCLA biochemists has brought scientists one step closer to developing treatments that could delay the onset of Alzheimer's disease and prevent the sexual transmission of HIV.

24 Jun 2011

Celgene announces data from REVLIMID plus rituximab Phase II study on malignant lymphomas

Celgene International Sàrl announced that clinical data from a Phase II study, conducted by investigators from the MD Anderson Cancer Center in Houston, TX, evaluating the combination regimen of REVLIMID plus rituximab (R2) in untreated, advanced stage, indolent B-cell non-Hodgkin's lymphomas, were presented at the 11th International Conference on Malignant Lymphoma in Lugano, Switzerland.

18 Jun 2011

Celgene, GELA to conduct REVLIMID/rituximab combination study on newly diagnosed FL

Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Celgene International Sarl today announced a collaboration to conduct an international randomized study to evaluate the therapeutic potential of the REVLIMID/rituximab combination regimen (R2) in patients with newly diagnosed follicular lymphoma.

17 Jun 2011

REVLIMID-R-CHOP Phase I/II data in untreated DLBCL presented at malignant lymphoma conference

Celgene International Sàrl announced that clinical data from two studies evaluating the use of REVLIMID® (lenalidomide) with standard R-CHOP chemotherapy in patients with untreated diffuse large B cell (DLBCL) or grade 3 follicular lymphoma were presented at the 11th International Conference on Malignant Lymphoma in Lugano, Switzerland.

17 Jun 2011

Celgene announces results of REVLIMID, docetaxel/prednisone phase II combination study on mCRPC

Celgene International Sàrl today announced results from a phase II investigator initiated study of REVLIMID (lenalidomide) in combination with Avastin (bevacizumab), docetaxel and prednisone in patients with metastatic castration-resistant prostate cancer were presented at the 2011 American Society of Clinical Oncology Annual Meeting in Chicago, Ill.

6 Jun 2011

Queen's University develops groundbreaking new test for male infertility

A groundbreaking new test for male infertility, which will save time, money and heartache for couples around the world, has been developed at Queen's University Belfast.

6 Jun 2011

SpermComet: New test for male infertility

A new test for male infertility will save time, money and heartache for couples around the world, scientists have claimed. Queen's University Belfast said that more than a decade's research by Professor Sheena Lewis, who leads its Reproductive Medicine research group, had delivered a medical breakthrough.

5 Jun 2011

Study shows positive link between percentage of motile sperm and serum vitamin D levels

Vitamin D is important for optimal reproductive function in both animals and humans. It has long been known that serum vitamin D level is important for reproductive function in various animals, but now researchers from the University of Copenhagen and Copenhagen University Hospital have shown that this relationship can also be demonstrated in humans.

26 May 2011

Offensive editorial leads to resignation of the president-elect of the American College of Surgeons

The president-elect of the American College of Surgeons had to resign from his position Sunday after weeks of controversy surrounding a Valentine’s Day editorial he wrote speaking of the mood-enhancing effects of semen on women during unprotected sex.

20 Apr 2011